Epigenetic and integrative cross-omics analyses of cerebral white matter hyperintensities on MRI
Cerebral white matter hyperintensities on MRI are markers of cerebral small vessel disease, a major risk factor for dementia and stroke. Despite the successful identification of multiple genetic variants associated with this highly heritable condition, its genetic architecture remains incompletely u...
Uloženo v:
| Vydáno v: | Brain (London, England : 1878) Ročník 146; číslo 2; s. 492 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
13.02.2023
|
| Témata: | |
| ISSN: | 1460-2156, 1460-2156 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Cerebral white matter hyperintensities on MRI are markers of cerebral small vessel disease, a major risk factor for dementia and stroke. Despite the successful identification of multiple genetic variants associated with this highly heritable condition, its genetic architecture remains incompletely understood. More specifically, the role of DNA methylation has received little attention. We investigated the association between white matter hyperintensity burden and DNA methylation in blood at ∼450 000 cytosine-phosphate-guanine (CpG) sites in 9732 middle-aged to older adults from 14 community-based studies. Single CpG and region-based association analyses were carried out. Functional annotation and integrative cross-omics analyses were performed to identify novel genes underlying the relationship between DNA methylation and white matter hyperintensities. We identified 12 single CpG and 46 region-based DNA methylation associations with white matter hyperintensity burden. Our top discovery single CpG, cg24202936 (P = 7.6 × 10-8), was associated with F2 expression in blood (P = 6.4 × 10-5) and co-localized with FOLH1 expression in brain (posterior probability = 0.75). Our top differentially methylated regions were in PRMT1 and in CCDC144NL-AS1, which were also represented in single CpG associations (cg17417856 and cg06809326, respectively). Through Mendelian randomization analyses cg06809326 was putatively associated with white matter hyperintensity burden (P = 0.03) and expression of CCDC144NL-AS1 possibly mediated this association. Differentially methylated region analysis, joint epigenetic association analysis and multi-omics co-localization analysis consistently identified a role of DNA methylation near SH3PXD2A, a locus previously identified in genome-wide association studies of white matter hyperintensities. Gene set enrichment analyses revealed functions of the identified DNA methylation loci in the blood-brain barrier and in the immune response. Integrative cross-omics analysis identified 19 key regulatory genes in two networks related to extracellular matrix organization, and lipid and lipoprotein metabolism. A drug-repositioning analysis indicated antihyperlipidaemic agents, more specifically peroxisome proliferator-activated receptor-alpha, as possible target drugs for white matter hyperintensities. Our epigenome-wide association study and integrative cross-omics analyses implicate novel genes influencing white matter hyperintensity burden, which converged on pathways related to the immune response and to a compromised blood-brain barrier possibly due to disrupted cell-cell and cell-extracellular matrix interactions. The results also suggest that antihyperlipidaemic therapy may contribute to lowering risk for white matter hyperintensities possibly through protection against blood-brain barrier disruption. |
|---|---|
| AbstractList | Cerebral white matter hyperintensities on MRI are markers of cerebral small vessel disease, a major risk factor for dementia and stroke. Despite the successful identification of multiple genetic variants associated with this highly heritable condition, its genetic architecture remains incompletely understood. More specifically, the role of DNA methylation has received little attention. We investigated the association between white matter hyperintensity burden and DNA methylation in blood at ∼450 000 cytosine-phosphate-guanine (CpG) sites in 9732 middle-aged to older adults from 14 community-based studies. Single CpG and region-based association analyses were carried out. Functional annotation and integrative cross-omics analyses were performed to identify novel genes underlying the relationship between DNA methylation and white matter hyperintensities. We identified 12 single CpG and 46 region-based DNA methylation associations with white matter hyperintensity burden. Our top discovery single CpG, cg24202936 (P = 7.6 × 10-8), was associated with F2 expression in blood (P = 6.4 × 10-5) and co-localized with FOLH1 expression in brain (posterior probability = 0.75). Our top differentially methylated regions were in PRMT1 and in CCDC144NL-AS1, which were also represented in single CpG associations (cg17417856 and cg06809326, respectively). Through Mendelian randomization analyses cg06809326 was putatively associated with white matter hyperintensity burden (P = 0.03) and expression of CCDC144NL-AS1 possibly mediated this association. Differentially methylated region analysis, joint epigenetic association analysis and multi-omics co-localization analysis consistently identified a role of DNA methylation near SH3PXD2A, a locus previously identified in genome-wide association studies of white matter hyperintensities. Gene set enrichment analyses revealed functions of the identified DNA methylation loci in the blood-brain barrier and in the immune response. Integrative cross-omics analysis identified 19 key regulatory genes in two networks related to extracellular matrix organization, and lipid and lipoprotein metabolism. A drug-repositioning analysis indicated antihyperlipidaemic agents, more specifically peroxisome proliferator-activated receptor-alpha, as possible target drugs for white matter hyperintensities. Our epigenome-wide association study and integrative cross-omics analyses implicate novel genes influencing white matter hyperintensity burden, which converged on pathways related to the immune response and to a compromised blood-brain barrier possibly due to disrupted cell-cell and cell-extracellular matrix interactions. The results also suggest that antihyperlipidaemic therapy may contribute to lowering risk for white matter hyperintensities possibly through protection against blood-brain barrier disruption. Cerebral white matter hyperintensities on MRI are markers of cerebral small vessel disease, a major risk factor for dementia and stroke. Despite the successful identification of multiple genetic variants associated with this highly heritable condition, its genetic architecture remains incompletely understood. More specifically, the role of DNA methylation has received little attention. We investigated the association between white matter hyperintensity burden and DNA methylation in blood at ∼450 000 cytosine-phosphate-guanine (CpG) sites in 9732 middle-aged to older adults from 14 community-based studies. Single CpG and region-based association analyses were carried out. Functional annotation and integrative cross-omics analyses were performed to identify novel genes underlying the relationship between DNA methylation and white matter hyperintensities. We identified 12 single CpG and 46 region-based DNA methylation associations with white matter hyperintensity burden. Our top discovery single CpG, cg24202936 (P = 7.6 × 10-8), was associated with F2 expression in blood (P = 6.4 × 10-5) and co-localized with FOLH1 expression in brain (posterior probability = 0.75). Our top differentially methylated regions were in PRMT1 and in CCDC144NL-AS1, which were also represented in single CpG associations (cg17417856 and cg06809326, respectively). Through Mendelian randomization analyses cg06809326 was putatively associated with white matter hyperintensity burden (P = 0.03) and expression of CCDC144NL-AS1 possibly mediated this association. Differentially methylated region analysis, joint epigenetic association analysis and multi-omics co-localization analysis consistently identified a role of DNA methylation near SH3PXD2A, a locus previously identified in genome-wide association studies of white matter hyperintensities. Gene set enrichment analyses revealed functions of the identified DNA methylation loci in the blood-brain barrier and in the immune response. Integrative cross-omics analysis identified 19 key regulatory genes in two networks related to extracellular matrix organization, and lipid and lipoprotein metabolism. A drug-repositioning analysis indicated antihyperlipidaemic agents, more specifically peroxisome proliferator-activated receptor-alpha, as possible target drugs for white matter hyperintensities. Our epigenome-wide association study and integrative cross-omics analyses implicate novel genes influencing white matter hyperintensity burden, which converged on pathways related to the immune response and to a compromised blood-brain barrier possibly due to disrupted cell-cell and cell-extracellular matrix interactions. The results also suggest that antihyperlipidaemic therapy may contribute to lowering risk for white matter hyperintensities possibly through protection against blood-brain barrier disruption.Cerebral white matter hyperintensities on MRI are markers of cerebral small vessel disease, a major risk factor for dementia and stroke. Despite the successful identification of multiple genetic variants associated with this highly heritable condition, its genetic architecture remains incompletely understood. More specifically, the role of DNA methylation has received little attention. We investigated the association between white matter hyperintensity burden and DNA methylation in blood at ∼450 000 cytosine-phosphate-guanine (CpG) sites in 9732 middle-aged to older adults from 14 community-based studies. Single CpG and region-based association analyses were carried out. Functional annotation and integrative cross-omics analyses were performed to identify novel genes underlying the relationship between DNA methylation and white matter hyperintensities. We identified 12 single CpG and 46 region-based DNA methylation associations with white matter hyperintensity burden. Our top discovery single CpG, cg24202936 (P = 7.6 × 10-8), was associated with F2 expression in blood (P = 6.4 × 10-5) and co-localized with FOLH1 expression in brain (posterior probability = 0.75). Our top differentially methylated regions were in PRMT1 and in CCDC144NL-AS1, which were also represented in single CpG associations (cg17417856 and cg06809326, respectively). Through Mendelian randomization analyses cg06809326 was putatively associated with white matter hyperintensity burden (P = 0.03) and expression of CCDC144NL-AS1 possibly mediated this association. Differentially methylated region analysis, joint epigenetic association analysis and multi-omics co-localization analysis consistently identified a role of DNA methylation near SH3PXD2A, a locus previously identified in genome-wide association studies of white matter hyperintensities. Gene set enrichment analyses revealed functions of the identified DNA methylation loci in the blood-brain barrier and in the immune response. Integrative cross-omics analysis identified 19 key regulatory genes in two networks related to extracellular matrix organization, and lipid and lipoprotein metabolism. A drug-repositioning analysis indicated antihyperlipidaemic agents, more specifically peroxisome proliferator-activated receptor-alpha, as possible target drugs for white matter hyperintensities. Our epigenome-wide association study and integrative cross-omics analyses implicate novel genes influencing white matter hyperintensity burden, which converged on pathways related to the immune response and to a compromised blood-brain barrier possibly due to disrupted cell-cell and cell-extracellular matrix interactions. The results also suggest that antihyperlipidaemic therapy may contribute to lowering risk for white matter hyperintensities possibly through protection against blood-brain barrier disruption. |
| Author | Debette, Stephanie Yang, Qiong Jiang, Jiyang Fornage, Myriam Satizabal, Claudia L Jhun, Min A Sorond, Farzaneh A Frenzel, Stefan Marquis, Pascale Vernooij, Meike W Yang, Yunju Kardia, Sharon L R Bourgey, Mathieu Grabe, Hans J Bis, Joshua C DeCarli, Charles S Lohner, Valerie Gottesman, Rebecca F Hosten, Norbert Mather, Karen A Mosley, Thomas H Sachdev, Perminder S Maniega, Susana Muñoz Boerwinkle, Eric Luciano, Michelle Sotoodehnia, Nona Breteler, Monique M B Longstreth, W T Bastin, Mark E Valdés Hernández, Maria C Hou, Lifang Zhao, Wei Deary, Ian J Psaty, Bruce M Mishra, Aniket van Duijn, Cornelia M Aziz, Nasir Ahmad Li, Shuo Ikram, M Arfan Armstrong, Nicola Seshadri, Sudha Launer, Lenore J Knol, Maria J Liu, Dan Teumer, Alexander Wang, Ruiqi Smith, Jennifer A Levy, Daniel Adams, Hieab H H Brody, Jennifer A Wittfeld, Katharina Wardlaw, Joanna |
| Author_xml | – sequence: 1 givenname: Yunju orcidid: 0000-0002-9747-8363 surname: Yang fullname: Yang, Yunju organization: Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science at Houston, Houston, TX 77030, USA – sequence: 2 givenname: Maria J orcidid: 0000-0002-3597-1531 surname: Knol fullname: Knol, Maria J organization: Department of Epidemiology, Erasmus MC University Medical Center, 3015 GD, Rotterdam, The Netherlands – sequence: 3 givenname: Ruiqi surname: Wang fullname: Wang, Ruiqi organization: Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA – sequence: 4 givenname: Aniket surname: Mishra fullname: Mishra, Aniket organization: University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team VINTAGE, UMR 1219, F-33000 Bordeaux, France – sequence: 5 givenname: Dan surname: Liu fullname: Liu, Dan organization: Population Health Sciences, German Centre for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany – sequence: 6 givenname: Michelle surname: Luciano fullname: Luciano, Michelle organization: Department of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK – sequence: 7 givenname: Alexander surname: Teumer fullname: Teumer, Alexander organization: Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Bialystok, 15-269, Poland – sequence: 8 givenname: Nicola surname: Armstrong fullname: Armstrong, Nicola organization: Mathematics and Statistics, Curtin University, 6845 Perth, Australia – sequence: 9 givenname: Joshua C surname: Bis fullname: Bis, Joshua C organization: Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA 02115, USA – sequence: 10 givenname: Min A surname: Jhun fullname: Jhun, Min A organization: Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48104, USA – sequence: 11 givenname: Shuo surname: Li fullname: Li, Shuo organization: Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA – sequence: 12 givenname: Hieab H H surname: Adams fullname: Adams, Hieab H H organization: Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, 3015 GD, Rotterdam, The Netherlands – sequence: 13 givenname: Nasir Ahmad surname: Aziz fullname: Aziz, Nasir Ahmad organization: Department of Neurology, Faculty of Medicine, University of Bonn, 53127 Bonn, Germany – sequence: 14 givenname: Mark E surname: Bastin fullname: Bastin, Mark E organization: Centre for Clinical Brain Sciences, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, EH8 9AB, UK – sequence: 15 givenname: Mathieu orcidid: 0000-0002-8432-834X surname: Bourgey fullname: Bourgey, Mathieu organization: Department for Human Genetics, McGill University Genome Centre, McGill University, Montréal, Quebec, Canada H3A 0G1 – sequence: 16 givenname: Jennifer A surname: Brody fullname: Brody, Jennifer A organization: Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA 02115, USA – sequence: 17 givenname: Stefan surname: Frenzel fullname: Frenzel, Stefan organization: Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald 17475, Germany – sequence: 18 givenname: Rebecca F surname: Gottesman fullname: Gottesman, Rebecca F organization: Stroke Branch, National Institutes of Neurological Disorders and Stroke, Bethesda, MD 20814, USA – sequence: 19 givenname: Norbert surname: Hosten fullname: Hosten, Norbert organization: Department of Radiology and Neuroradiology, University Medicine Greifswald, 17475 Greifswald, Germany – sequence: 20 givenname: Lifang surname: Hou fullname: Hou, Lifang organization: Department of Preventive Medicine, Northwestern University, Chicago, IL 60611, USA – sequence: 21 givenname: Sharon L R surname: Kardia fullname: Kardia, Sharon L R organization: Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48104, USA – sequence: 22 givenname: Valerie surname: Lohner fullname: Lohner, Valerie organization: Population Health Sciences, German Centre for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany – sequence: 23 givenname: Pascale surname: Marquis fullname: Marquis, Pascale organization: Department for Human Genetics, McGill University Genome Centre, McGill University, Montréal, Quebec, Canada H3A 0G1 – sequence: 24 givenname: Susana Muñoz surname: Maniega fullname: Maniega, Susana Muñoz organization: Centre for Clinical Brain Sciences, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, EH8 9AB, UK – sequence: 25 givenname: Claudia L surname: Satizabal fullname: Satizabal, Claudia L organization: Department of Neurology, Boston University School of Medicine, Boston, MA 02115, USA – sequence: 26 givenname: Farzaneh A surname: Sorond fullname: Sorond, Farzaneh A organization: Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA – sequence: 27 givenname: Maria C surname: Valdés Hernández fullname: Valdés Hernández, Maria C organization: Centre for Clinical Brain Sciences, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, EH8 9AB, UK – sequence: 28 givenname: Cornelia M orcidid: 0000-0002-2374-9204 surname: van Duijn fullname: van Duijn, Cornelia M organization: Nuffield Department of Population Health, Oxford University, Oxford, OX3 7LF, UK – sequence: 29 givenname: Meike W orcidid: 0000-0003-4658-2176 surname: Vernooij fullname: Vernooij, Meike W organization: Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, 3015 GD, Rotterdam, The Netherlands – sequence: 30 givenname: Katharina surname: Wittfeld fullname: Wittfeld, Katharina organization: German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, 17475 Rostock, Germany – sequence: 31 givenname: Qiong orcidid: 0000-0002-3658-1375 surname: Yang fullname: Yang, Qiong organization: The Framingham Heart Study, Framingham, MA 01701, USA – sequence: 32 givenname: Wei surname: Zhao fullname: Zhao, Wei organization: Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48104, USA – sequence: 33 givenname: Eric surname: Boerwinkle fullname: Boerwinkle, Eric organization: Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA – sequence: 34 givenname: Daniel surname: Levy fullname: Levy, Daniel organization: Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20814, USA – sequence: 35 givenname: Ian J surname: Deary fullname: Deary, Ian J organization: Department of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK – sequence: 36 givenname: Jiyang surname: Jiang fullname: Jiang, Jiyang organization: Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia – sequence: 37 givenname: Karen A orcidid: 0000-0003-4143-8941 surname: Mather fullname: Mather, Karen A organization: Neuroscience Research Australia, Sydney, NSW 2031, Australia – sequence: 38 givenname: Thomas H surname: Mosley fullname: Mosley, Thomas H organization: The Memory Impairment Neurodegenerative Dementia (MIND) Research Center, University of Mississippi Medical Center, Jackson, MS 39216, USA – sequence: 39 givenname: Bruce M surname: Psaty fullname: Psaty, Bruce M organization: Department of Epidemiology, University of Washington, Seattle, WA 98104, USA – sequence: 40 givenname: Perminder S orcidid: 0000-0002-9595-3220 surname: Sachdev fullname: Sachdev, Perminder S organization: Neuropsychiatric Institute, The Prince of Wales Hospital, University of New South Wales, Randwick, NSW 2031, Australia – sequence: 41 givenname: Jennifer A orcidid: 0000-0002-3575-5468 surname: Smith fullname: Smith, Jennifer A organization: Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48104, USA – sequence: 42 givenname: Nona surname: Sotoodehnia fullname: Sotoodehnia, Nona organization: Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA 02115, USA – sequence: 43 givenname: Charles S surname: DeCarli fullname: DeCarli, Charles S organization: Department of Neurology and Center for Neuroscience, University of California at Davis, Sacramento, CA 95816, USA – sequence: 44 givenname: Monique M B surname: Breteler fullname: Breteler, Monique M B organization: Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), Faculty of Medicine, University of Bonn, 53127 Bonn, Germany – sequence: 45 givenname: M Arfan surname: Ikram fullname: Ikram, M Arfan organization: Department of Epidemiology, Erasmus MC University Medical Center, 3015 GD, Rotterdam, The Netherlands – sequence: 46 givenname: Hans J surname: Grabe fullname: Grabe, Hans J organization: German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, 17475 Rostock, Germany – sequence: 47 givenname: Joanna surname: Wardlaw fullname: Wardlaw, Joanna organization: Centre for Clinical Brain Sciences, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, EH8 9AB, UK – sequence: 48 givenname: W T surname: Longstreth fullname: Longstreth, W T organization: Department of Neurology, University of Washington, Seattle, WA 98104, USA – sequence: 49 givenname: Lenore J surname: Launer fullname: Launer, Lenore J organization: Intramural Research Program, National Institute on Aging, National Institutes of Health, Bethesda, MD 20814, USA – sequence: 50 givenname: Sudha surname: Seshadri fullname: Seshadri, Sudha organization: Department of Neurology, Boston University School of Medicine, Boston, MA 02115, USA – sequence: 51 givenname: Stephanie orcidid: 0000-0001-6950-984X surname: Debette fullname: Debette, Stephanie organization: CHU de Bordeaux, Department of Neurology, F-33000 Bordeaux, France – sequence: 52 givenname: Myriam surname: Fornage fullname: Fornage, Myriam organization: Human Genetics Center, School of Public Health, University of Texas Health Science at Houston, Houston, TX 77030, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35943854$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkM1LAzEUxINU7IcevUqOXta-JPuRHqVULVQE0fOaTd62kd3smqSW_ve2WMHTDMxv3oMZk4HrHBJyzeCOwUxMK6-sm6qd0nwGZ2TE0hwSzrJ88M8PyTiETwCWCp5fkKHIZqmQWToiH4vertFhtJoqZ6h1EddeRfuNVPsuhKRrrQ6HTDX7gIF2NdXo8fC2obuNjUhbFSN6utn36I91F2y0R9LR59flJTmvVRPw6qQT8v6weJs_JauXx-X8fpXolLOYCMZNlcmiMIWUlcBcMQkpA8UZpMhAAuRZbiSiYVUtFNTa1CbNjQKNmhd8Qm5_7_a--9piiGVrg8amUQ67bSh5ASCYKLg8oDcndFu1aMre21b5ffm3Cv8BPsxoBQ |
| CitedBy_id | crossref_primary_10_1161_STROKEAHA_124_045903 crossref_primary_10_1002_ana_26648 crossref_primary_10_1038_s41380_023_02067_2 crossref_primary_10_1371_journal_pone_0329859 crossref_primary_10_1017_cjn_2024_26 crossref_primary_10_1016_j_mri_2025_110339 crossref_primary_10_1038_s41582_025_01105_7 crossref_primary_10_3390_cimb46010060 crossref_primary_10_3389_fgene_2024_1325401 crossref_primary_10_1007_s10238_025_01818_5 crossref_primary_10_1016_j_ncl_2024_03_003 crossref_primary_10_3389_fneur_2024_1470441 crossref_primary_10_1161_STROKEAHA_123_044174 crossref_primary_10_1186_s12967_023_04677_4 crossref_primary_10_1002_mco2_315 crossref_primary_10_1186_s12885_025_14095_y crossref_primary_10_1186_s13148_023_01589_4 crossref_primary_10_3390_ijms25084452 crossref_primary_10_1503_jpn_240039 crossref_primary_10_1186_s42466_024_00327_2 crossref_primary_10_3390_ijms25020887 crossref_primary_10_1016_j_bbi_2023_10_019 crossref_primary_10_1161_JAHA_123_029862 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. |
| Copyright_xml | – notice: The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1093/brain/awac290 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1460-2156 |
| ExternalDocumentID | 35943854 |
| Genre | Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: Medical Research Council grantid: MR/M013111/1 – fundername: Medical Research Council grantid: MR/J006971/1 – fundername: NINDS NIH HHS grantid: R01 NS017950 – fundername: NHLBI NIH HHS grantid: R01 HL105756 – fundername: Medical Research Council grantid: G1001245 – fundername: NIA NIH HHS grantid: RF1 AG059421 – fundername: NIA NIH HHS grantid: P30 AG072972 – fundername: Medical Research Council grantid: MR/K026992/1 – fundername: NINDS NIH HHS grantid: RF1 NS085002 – fundername: NIA NIH HHS grantid: U01 AG052409 |
| GroupedDBID | --- -E4 -~X .2P .I3 .XZ .ZR 0R~ 1TH 23N 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6PF 70D AABZA AACZT AAIMJ AAJKP AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAVAP AAVLN AAWTL ABDFA ABEJV ABEUO ABGNP ABIVO ABIXL ABJNI ABKDP ABLJU ABMNT ABNHQ ABNKS ABPQP ABPTD ABQLI ABQNK ABVGC ABWST ABXVV ABXZS ABZBJ ACGFS ACIWK ACPRK ACUFI ACUTO ACYHN ADBBV ADEYI ADEZT ADGKP ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AELWJ AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFXAL AFYAG AGINJ AGKEF AGORE AGQXC AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AIJHB AJBYB AJEEA AJNCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ARIXL ATGXG AXUDD AYOIW BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BR6 BSWAC BTRTY BVRKM C45 CDBKE CGR COF CS3 CUY CVF CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBS ECM EE~ EIF EMOBN ENERS F5P F9B FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 J5H JXSIZ KAQDR KOP KQ8 KSI KSN L7B M-Z MHKGH ML0 N9A NGC NLBLG NOMLY NOYVH NPM O9- OAUYM OAWHX OBOKY OCZFY ODMLO OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX RUSNO RW1 RXO TCURE TEORI TJX TLC TR2 VVN W8F WH7 WOQ X7H YAYTL YKOAZ YSK YXANX ZKX ~91 7X8 NU- |
| ID | FETCH-LOGICAL-c421t-312db5877d788b3e6a180410a2104e10800656d8eed1bf3a0fcdfd46da0cec272 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 25 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000897586800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1460-2156 |
| IngestDate | Sun Sep 28 02:10:08 EDT 2025 Sat May 31 02:12:07 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | blood–brain barrier dysfunction cerebral small vessel disease epigenome-wide association study integrative cross-omics analysis white matter hyperintensities |
| Language | English |
| License | The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c421t-312db5877d788b3e6a180410a2104e10800656d8eed1bf3a0fcdfd46da0cec272 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-8432-834X 0000-0002-3597-1531 0000-0002-3658-1375 0000-0002-9595-3220 0000-0002-2374-9204 0000-0003-4658-2176 0000-0002-3575-5468 0000-0003-4143-8941 0000-0001-6950-984X 0000-0002-9747-8363 |
| OpenAccessLink | https://academic.oup.com/brain/article-pdf/146/2/492/49171700/awac290.pdf |
| PMID | 35943854 |
| PQID | 2700313728 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2700313728 pubmed_primary_35943854 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-02-13 |
| PublicationDateYYYYMMDD | 2023-02-13 |
| PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-13 day: 13 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Brain (London, England : 1878) |
| PublicationTitleAlternate | Brain |
| PublicationYear | 2023 |
| SSID | ssj0014326 |
| Score | 2.5423396 |
| Snippet | Cerebral white matter hyperintensities on MRI are markers of cerebral small vessel disease, a major risk factor for dementia and stroke. Despite the successful... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 492 |
| SubjectTerms | Aged Brain - diagnostic imaging DNA Methylation - genetics Epigenesis, Genetic Genome-Wide Association Study - methods Humans Magnetic Resonance Imaging Middle Aged Protein-Arginine N-Methyltransferases Repressor Proteins White Matter - diagnostic imaging |
| Title | Epigenetic and integrative cross-omics analyses of cerebral white matter hyperintensities on MRI |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35943854 https://www.proquest.com/docview/2700313728 |
| Volume | 146 |
| WOSCitedRecordID | wos000897586800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3IvgaljZpmzyJyIY-bAxR2FvNckFB27lOh__enDZjT4LgS19CoSSn55LvnO9D6Iob0LD23k9rmhCAzoiQmhGnrHBOcSsdr8UmssFAjEZyGC7cqtBWufCJtaM2pYY78g4ApCxiWSyuJx8EVKMAXQ0SGquo5dckWHU2WqIInMVhuogSH9rSwLHpi_jOGAQYOmqudCzp79llHWV62__9vh20FfJLfNMYxC5ascUe2ugHBH0fPXcnwL8Jo4tYFQYv6CK808N1xCQwplz5NSArsRUuHdZ2CvDyG54D5oDfa0pO_PINJMlNBzywsuKywP2H-wP01Os-3t6RoLJANI-jmXfCsRknIsuMr4bHzKYqAk4iqnwxyC20IPosJTXCB9No7JiiThtneGoU1VbHWXyI1oqysMcIR1IJZWiiMsO4P2yZOA0E9gmjzicGrI0uF3uXeysGaEIVtvys8uXutdFRcwD5pKHbyFkiORMJP_nD26doE_Tgoa06Ymeo5fw_bM_Ruv6avVbTi9o8_HMw7P8AIOrGxA |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epigenetic+and+integrative+cross-omics+analyses+of+cerebral+white+matter+hyperintensities+on+MRI&rft.jtitle=Brain+%28London%2C+England+%3A+1878%29&rft.au=Yang%2C+Yunju&rft.au=Knol%2C+Maria+J&rft.au=Wang%2C+Ruiqi&rft.au=Mishra%2C+Aniket&rft.date=2023-02-13&rft.eissn=1460-2156&rft.volume=146&rft.issue=2&rft.spage=492&rft_id=info:doi/10.1093%2Fbrain%2Fawac290&rft_id=info%3Apmid%2F35943854&rft_id=info%3Apmid%2F35943854&rft.externalDocID=35943854 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2156&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2156&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2156&client=summon |